In recent years, reverse patent settlement agreements — whereby a patent holder pays or gives other forms of value to an infringer in order to avoid or to settle patent litigation — have raised considerable debate in the pharmaceutical field in both the United States and the European Union,...

Introduction -- Which horizontal agreements are illegal? -- What unilateral conduct is illegal? -- Vertical agreements that restrict dealing with rivals -- Distorting downstream distribution of a supplier's products -- Proving an agreement or concerted action -- Mergers and acquisitions --...